Member Info for Doc83

Apologies, I think I’ve asked this before but do we have any idea or any hints as to how many drugs will be trialled on strive, and also how regularly they might now confirm the candidates following confirmation it is going ahead?

Presumably they do want a push for winter so would hope there is regular news on new candidates.

“don't waste your breath on the heshe.”

Lol. Especially one that can’t do basic math with dates.

Docdaneeka - it was very much said tongue in cheek ref the £40bn! The point was more that a JV could still yield us some nice returns if SNG001 gets commercialised and is as good as we hope it is.

I meant to say Moderna and BioNTech. I’m sure they added about £40bn to their market cap. I’d be satisfied with that kind of performance from Synairgen!

Baby steps, though. Let’s get back to the 35p being mooted as a TO price!

Size82, if a JV worked out as successful as it did for the likes of Pfizer or BioNTech, I’d be ok with that!

Docdaneeka, your metaphors crack me up! Not your best but still made me smile.

“The first racer has his skates on and is away across the polders.”

I also hope JoeyDiamond’s long shot coincidences are anything but.

TommyD, couldn’t agree more. For them to spend all that time, money and resource on a P2 trial which SNG then passed, to just give up on it would IMO be at best negligent and a waste of public money.

Any ideas whatsoever when the next candidate for strive might be announced, or how frequently?

Aether, who knows. Albert Bourla might have taken RM for a round of golf and put some feelers out. We'd be the last to know.

Hi levistubbs, can you let me know where I can view the recording?

Guys I missed it bathing the little one. Anyone care to summarise in a few lines, or is it recorded somewhere?

Ghia, you say they seem less bothered about the price they pay. But I’d say their buying has been glacially slow. Months in between 1% TR1’s. They’ve bought very well IMO. Well, I suppose we’ll really find out just how well they have bought in time!

Professional: "Poly buys the 70% they do not own for 35p which makes 50 mln.
They sell 100% to pharma which they already did the deal with at 50p..."

I’d assumed Polygon paid an average of £1.50 for their original 18% or £54m. They’ve bought another 20m shares for let’s say 25p. Could me more, could be less but we talking small numbers overall. Let’s call it a round £60m for 30% of the stock. Another £49m for the remaining 70% at 35p. So approx £110m. Now they sell 200m shares to large pharma for 50p or £100m… wow, £10m big profit!!!

Even if they paid an average of £1 pre Feb, it’s a nothing profit for the level of risk they have taken.

This is a nonsense debate. No way would they persuade more than 90% of shareholders to give up their shares for 35p! Not unless they start spreading false news to send the SP into the gutter and spook investors.

Stay strong, people!

Professional: "Poly buys the 70% they do not own for 35p which makes 50 mln.
They sell 100% to pharma which they already did the deal with at 50p..."

Refer to Tommy's point. Why would large pharma buy through Polygon at 50p when they could just bid 35p themselves?!

I'd rather be diluted then sell out for 35p.

Circumstances might change where 35p ends up looking like a great result. But not yet or even in February. Any bidder, be it Polygon or big pharma, would need to persuade 90% of shareholders to agree to it to force everyone else to give up their shares. Now for me I won't be considering any bids sub £1. Probably £2. And I have significantly increased my holding where that would realise a very nice profit. 35p... I'd rather see the shares go to 0p than let someone have mine for that. But as said above, if we're further down the line and there's been bad news, I might be glad of 35p.

Anyway, put another way we'd need 10% of shareholders to decline any daft bids. Bear in mind the BOD and employees of Synairgen hold a decent chunk of shares. Here's some from the share register:

Simon Shaw - 0.76%
Richard Marsden - 0.49%
Stephen Holgate - 0.44%
Ratko Djukanovic - 0.42%
John Ward - 0.36%
Phillip Monk - 0.21%

Then they'll be others staff who hold through brokers. I also know of another decently sized holder or two who won't be selling out cheap... ;)

The point is, any bidder will need the BOD and Synairgen staffers on board...and me ;) Is SSH and RM (on his inflated salary that MrCosts loves to mention) really going to give up a lifetime of work for 35p? I doubt it.

A final word on Polygon. Even for their size, dropping what would be £100m+ on a tiny micro stock would be quite the punt. They'd have to have some serious conviction and after February I'm sure even they will be wary of how sour things can go. So far they have spent a tiny amount post Feb relative to their overall cost. To spend another say £50m to buy it out entirely, that I just don't see. And if things are looking a bit rosier (i.e. trials are set up) then they'll need to spend much more. I just don't see it.

Docdaneeka - you might be able to see a better pic than I’m looking at, but looking at other name tags suggests the names are nicely centred. So it looks to me like at least 4 letters, maybe 5 for the surname. I’m also not seeing a V but perhaps a H and A as the first two letters?

I’ve had a good look through Twitter for posts with idweek2022 tagged to see if I could see him but no joy.

Titania, that’s the best shout so far! I’ve blown up the images and looked at them side by side and am still not completely sure. If it’s not, it’s a very good look-a-like!

Mrcosts - I think everyone on here knows what your opinion is of SNG.

Dunk and Gunto make fair points, though. If you are convinced this is doomed, sell while you can? If there is a hint of potential positivity that is keeping you invested, let’s hear it.

MrCosts, there’s plenty of people on here that aren’t apparently as rich as you. Some who have put their life savings into this. So do you think your relentless negativity helps them sleep better at night?

I took a relatively small position here a few weeks ago after a recommendation from an astute investor friend, albeit with the caveat that it’s obviously a high risk play.

For those criticising PJ and his regular communication along with all the RNS’s, I can tell you as a long suffering shareholder of SNG, who rarely communicate and which is debated on here ad nauseum, that it’s quite refreshing!

Mani - pfft, imaginary?! Poor Maud.